Autopsy report · NCT02026960

RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)

“The sponsor's clinical program for the agent used in this study was discontinued.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 3 years 6 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Duke University

Sponsor type

University, hospital or other

Conditions

Metastatic Renal Cell Carcinoma; Genitourinary Cancer (Bladder, Prostate or Testicular)

Interventions

RNA extraction and amplification from biopsy specimens

Participants

14

Sites

1

Countries

United States

Trials that died the same way

• Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
  “Funding for this study was discontinued by the sponsor after the first year.” (81% match in meaning)
• KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
  “Study discontinued due to sponsor decision.” (79% match in meaning)
• Safety and Efficacy of MAGE-A3/A6 T Cell Receptor Engineered T Cells (KITE-718) in HLA-DPB1*04:01 Positive Adults With Advanced Cancers
  “The study was terminated due to the sponsor's decision to discontinue the clinical trial.” (78% match in meaning)
• Study of Access Site for Enhancing PCI in STEMI for Seniors (SAFE STEMI for Seniors)
  “Funding for this study has been discontinued.” (77% match in meaning)
• Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
  “This study was terminated by the Sponsor.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.